Sepsis-induced coagulopathy (SIC) in the management of sepsis.

COI Statement

Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The author declares there are no competing interests.

References:

• Iba T, Helms J, Levy JH. Sepsis-induced coagulopathy (SIC) in the management of sepsis. Ann Intensive Care. 2024;14(1):148.
• Hartmann J, Hermelin D, Levy JH. Viscoelastic testing: an illustrated review of technology and clinical applications. Res Pract Thromb Haemost. 2023;7(1):100031.
• Bui-Thi HD, Le Minh K. Coagulation profiles in patients with sepsis/septic shock identify mixed hypo-hypercoagulation patterns based on rotational thromboelastometry: A prospective observational study. Thromb Res. 2023;227:51 − 9.
• Kim SM, Kim SI, Yu G, Kim YJ, Kim WY. Which Septic Shock Patients With Non-Overt DIC Progress to DIC After Admission? Point-of-Care Thromboelastography Testing. Shock (Augusta, Ga). 2022;57(2):168 − 74.
• Kim SM, Kim SI, Yu G, Kim JS, Hong SI, Chae B, et al. Role of thromboelastography in the evaluation of septic shock patients with normal prothrombin time and activated partial thromboplastin time. Sci Rep. 2021;11(1):11833.